pioglitazone has been researched along with Osteoarthritis of Knee in 2 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Xue, X | 1 |
Dai, T | 1 |
Chen, J | 1 |
Xu, Y | 1 |
Yang, Z | 1 |
Huang, J | 1 |
Xu, W | 1 |
Li, S | 1 |
Meng, Q | 1 |
Li, Y | 1 |
Zhang, Y | 1 |
Chen, C | 1 |
Zhang, H | 1 |
Ma, C | 1 |
Xia, Y | 1 |
2 other studies available for pioglitazone and Osteoarthritis of Knee
Article | Year |
---|---|
PPARĪ³ activation suppresses chondrocyte ferroptosis through mitophagy in osteoarthritis.
Topics: Animals; Chondrocytes; Ferroptosis; Mitophagy; Osteoarthritis, Knee; Pioglitazone; PPAR gamma; Prote | 2023 |
Establishment of a rabbit model to study the influence of advanced glycation end products accumulation on osteoarthritis and the protective effect of pioglitazone.
Topics: Animals; Cartilage, Articular; Disease Models, Animal; Glycation End Products, Advanced; Hypoglycemi | 2016 |